Global Hepatitis A Vaccine Market Research Report 2021
Global Hepatitis A Vaccine Market Research Report 2021
The Hepatitis A Vaccine study provides a comprehensive overview of safety standards, market penetration, and innovation pipelines across major economies.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Research Predicts that Hepatitis A Vaccine Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Hepatitis A Vaccine Market Overview:
Global Hepatitis A Vaccine Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Hepatitis A Vaccine involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Hepatitis A Vaccine Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Hepatitis A Vaccine market in 2020.
Global Hepatitis A Vaccine Market Segmentation
By Type, Hepatitis A Vaccine market has been segmented into:
Liver Inactivated Vaccine
Live Attenuated Vaccine
By Application, Hepatitis A Vaccine market has been segmented into:
Hospitals
Other Medical Institutions
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Hepatitis A Vaccine market are:
GlaxoSmithKline
Merck Sharp & Dohme Corp
SANOFI PASTEUR S.A
Norvatis
Crucell Switzerland AG(Berna+Crucell)
China Academy of Medical Sciences
Changchun Institute of Biological Products
Zhejiang Pukang
ChangSheng
Sinovac
Shanghai Zerun Biotechnology
1. Market Overview of Hepatitis A Vaccine
1.1 Hepatitis A Vaccine Market Overview
1.1.1 Hepatitis A Vaccine Product Scope
1.1.2 Market Status and Outlook
1.2 Hepatitis A Vaccine Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Hepatitis A Vaccine Historic Market Size by Regions (2015-2020)
1.4 Hepatitis A Vaccine Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Hepatitis A Vaccine Sales Market by Type (2015-2026)
2.1 Global Hepatitis A Vaccine Historic Market Size by Type (2015-2020)
2.2 Global Hepatitis A Vaccine Forecasted Market Size by Type (2021-2026)
2.3 Liver Inactivated Vaccine
2.4 Live Attenuated Vaccine
3. Covid-19 Impact Hepatitis A Vaccine Sales Market by Application (2015-2026)
3.1 Global Hepatitis A Vaccine Historic Market Size by Application (2015-2020)
3.2 Global Hepatitis A Vaccine Forecasted Market Size by Application (2021-2026)
3.3 Hospitals
3.4 Other Medical Institutions
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Hepatitis A Vaccine Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Hepatitis A Vaccine Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Hepatitis A Vaccine Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Hepatitis A Vaccine Business
5.1 GlaxoSmithKline
5.1.1 GlaxoSmithKline Company Profile
5.1.2 GlaxoSmithKline Hepatitis A Vaccine Product Specification
5.1.3 GlaxoSmithKline Hepatitis A Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 Merck Sharp & Dohme Corp
5.2.1 Merck Sharp & Dohme Corp Company Profile
5.2.2 Merck Sharp & Dohme Corp Hepatitis A Vaccine Product Specification
5.2.3 Merck Sharp & Dohme Corp Hepatitis A Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 SANOFI PASTEUR S.A
5.3.1 SANOFI PASTEUR S.A Company Profile
5.3.2 SANOFI PASTEUR S.A Hepatitis A Vaccine Product Specification
5.3.3 SANOFI PASTEUR S.A Hepatitis A Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 Norvatis
5.4.1 Norvatis Company Profile
5.4.2 Norvatis Hepatitis A Vaccine Product Specification
5.4.3 Norvatis Hepatitis A Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 Crucell Switzerland AG(Berna+Crucell)
5.5.1 Crucell Switzerland AG(Berna+Crucell) Company Profile
5.5.2 Crucell Switzerland AG(Berna+Crucell) Hepatitis A Vaccine Product Specification
5.5.3 Crucell Switzerland AG(Berna+Crucell) Hepatitis A Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 China Academy of Medical Sciences
5.6.1 China Academy of Medical Sciences Company Profile
5.6.2 China Academy of Medical Sciences Hepatitis A Vaccine Product Specification
5.6.3 China Academy of Medical Sciences Hepatitis A Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 Changchun Institute of Biological Products
5.7.1 Changchun Institute of Biological Products Company Profile
5.7.2 Changchun Institute of Biological Products Hepatitis A Vaccine Product Specification
5.7.3 Changchun Institute of Biological Products Hepatitis A Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 Zhejiang Pukang
5.8.1 Zhejiang Pukang Company Profile
5.8.2 Zhejiang Pukang Hepatitis A Vaccine Product Specification
5.8.3 Zhejiang Pukang Hepatitis A Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 ChangSheng
5.9.1 ChangSheng Company Profile
5.9.2 ChangSheng Hepatitis A Vaccine Product Specification
5.9.3 ChangSheng Hepatitis A Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.10 Sinovac
5.10.1 Sinovac Company Profile
5.10.2 Sinovac Hepatitis A Vaccine Product Specification
5.10.3 Sinovac Hepatitis A Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.11 Shanghai Zerun Biotechnology
5.11.1 Shanghai Zerun Biotechnology Company Profile
5.11.2 Shanghai Zerun Biotechnology Hepatitis A Vaccine Product Specification
5.11.3 Shanghai Zerun Biotechnology Hepatitis A Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Hepatitis A Vaccine Market Size (2015-2026)
6.2 North America Hepatitis A Vaccine Key Players in North America (2015-2020)
6.3 North America Hepatitis A Vaccine Market Size by Type (2015-2020)
6.4 North America Hepatitis A Vaccine Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Hepatitis A Vaccine Market Size (2015-2026)
7.2 East Asia Hepatitis A Vaccine Key Players in North America (2015-2020)
7.3 East Asia Hepatitis A Vaccine Market Size by Type (2015-2020)
7.4 East Asia Hepatitis A Vaccine Market Size by Application (2015-2020)
8. Europe
8.1 Europe Hepatitis A Vaccine Market Size (2015-2026)
8.2 Europe Hepatitis A Vaccine Key Players in North America (2015-2020)
8.3 Europe Hepatitis A Vaccine Market Size by Type (2015-2020)
8.4 Europe Hepatitis A Vaccine Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Hepatitis A Vaccine Market Size (2015-2026)
9.2 South Asia Hepatitis A Vaccine Key Players in North America (2015-2020)
9.3 South Asia Hepatitis A Vaccine Market Size by Type (2015-2020)
9.4 South Asia Hepatitis A Vaccine Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Hepatitis A Vaccine Market Size (2015-2026)
10.2 Southeast Asia Hepatitis A Vaccine Key Players in North America (2015-2020)
10.3 Southeast Asia Hepatitis A Vaccine Market Size by Type (2015-2020)
10.4 Southeast Asia Hepatitis A Vaccine Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Hepatitis A Vaccine Market Size (2015-2026)
11.2 Middle East Hepatitis A Vaccine Key Players in North America (2015-2020)
11.3 Middle East Hepatitis A Vaccine Market Size by Type (2015-2020)
11.4 Middle East Hepatitis A Vaccine Market Size by Application (2015-2020)
12. Africa
12.1 Africa Hepatitis A Vaccine Market Size (2015-2026)
12.2 Africa Hepatitis A Vaccine Key Players in North America (2015-2020)
12.3 Africa Hepatitis A Vaccine Market Size by Type (2015-2020)
12.4 Africa Hepatitis A Vaccine Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Hepatitis A Vaccine Market Size (2015-2026)
13.2 Oceania Hepatitis A Vaccine Key Players in North America (2015-2020)
13.3 Oceania Hepatitis A Vaccine Market Size by Type (2015-2020)
13.4 Oceania Hepatitis A Vaccine Market Size by Application (2015-2020)
14. South America
14.1 South America Hepatitis A Vaccine Market Size (2015-2026)
14.2 South America Hepatitis A Vaccine Key Players in North America (2015-2020)
14.3 South America Hepatitis A Vaccine Market Size by Type (2015-2020)
14.4 South America Hepatitis A Vaccine Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Hepatitis A Vaccine Market Size (2015-2026)
15.2 Rest of the World Hepatitis A Vaccine Key Players in North America (2015-2020)
15.3 Rest of the World Hepatitis A Vaccine Market Size by Type (2015-2020)
15.4 Rest of the World Hepatitis A Vaccine Market Size by Application (2015-2020)
16 Hepatitis A Vaccine Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Research Methodology:
Hepatitis A Vaccine Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|